MedPath

CEUS targeted biopsies compared to mpMRI targeted and systematic biopsies for the detection of Prostate Cancer.

Completed
Conditions
Prostate adenocarcinoma
Prostate cancer
10038364
Registration Number
NL-OMON44958
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
299
Inclusion Criteria

- Scheduled for prostate biopsy
- Over 18 years
- Signed informed consent
- mpMRI data available

Exclusion Criteria

- Has documented acute prostatitis or urinary tract infections
- History of any clinically evidence of cardiac right-to-left shunts
- Receives treatment that includes dobutamine
- Has severe pulmonary hypertension (pulmonary artery pressure >90 mmHg) or uncontrolled systemic hypertension or respiratory distress syndrome
- Has received a biopsy procedure within 30 days before admission into this study
- Has any medical condition or other circumstances which would significantly decrease the chances of obtaining reliable data, achieving study objectives, or completing the study
- Is incapable of understanding the language in which the information for the patient is given
- Has received a biopsy procedure at the AMC within a year before admission into this study

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath